Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
François-Clément Bidard1,2, Dieter J Peeters3,4, Tanja Fehm5, Franco Nolé6, Rafael Gisbert-Criado7, Dimitrios Mavroudis8, Salvatore Grisanti9, Daniele Generali10, Jose A Garcia-Saenz11, Justin Stebbing12, Carlos Caldas13,14,15, Paola Gazzaniga16, Luis Manso17, Rita Zamarchi18, Angela Fernandez de Lascoiti19, Leticia De Mattos-Arruda20, Michail Ignatiadis21, Ronald Lebofsky1, Steven J van Laere3,4,22, Franziska Meier-Stiegen5
1Department of Medical Oncology and SIRIC, Institut Curie, Paris, France
2Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
3Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium
4University of Antwerp, Antwerp, Belgium
5Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
6Division of Medical Senology, European Institute of Oncology, Milan, Italy
7Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain
8University Hospital of Heraklion, Heraklion, Greece
9Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy
10AZ Istituti Ospitalieri di Cremona, Cremona, Italy
11Department of Oncology, Hospital Clinico San Carlos, Department of Medicine, University Complutense of Madrid, Spain
12Imperial College and Imperial College Healthcare NHS Trust, London, UK
13Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK
14Cambridge Experimental Cancer Medicine Centre, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK
15Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge, UK
16Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
17Hospital 12 de Octubre, Madrid, Spain
18IOV-IRCCS, Padova, Italy
19Hospital de Navarra, Pamplona, Spain
20Val d’Hebron Institute of Oncology, Val d’Hebron University Hospital, and Universitat Autònoma de Barcelona, Barcelona, Spain
21Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
22Department of Oncology, KU Leuven, Leuven, Belgium
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
The Lancet Oncology
Tập 15
406-414
Thông tin tác giả